PHS
PDCO

PFM Health Sciences’s Patterson Companies, Inc. PDCO Stock Holding History

PFM Health Sciences’s Portfolio PDCO Stock Details PDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-635,863
Closed -$28.8M – 116
2017
Q1 		$28.8M Buy
635,863
+136,533
+27% +$5.92M 0.72% 55
2016
Q4 		$20.5M Buy
+499,330
New +$21.5M 0.58% 58
2015
Q2 		– Sell
-531,218
Closed -$25.9M – 111
2015
Q1 		$25.9M Buy
531,218
+263,828
+99% +$13.1M 0.71% 51
2014
Q4 		$12.9M Buy
+267,390
New +$12M 0.3% 72

Other funds holding PDCO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PFM Health Sciences's PDCO Position: Q2 2017 in Review

PFM Health Sciences sold out of Patterson Companies, Inc. (PDCO) in Q2 2017, closing a stake of 635,863 shares — an estimated $28.8M sold.

PFM Health Sciences first reported a position in PDCO in Q4 2014 and held it in 4 quarters. The position peaked at $28.8M in Q1 2017. 397 funds tracked by Wall St. Rank hold PDCO as of Q2 2017.

  • PFM Health Sciences reported no remaining Patterson Companies, Inc. position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 635,863 Patterson Companies, Inc. shares in Q2 2017, an estimated $28.8M.
  • PFM Health Sciences first reported a position in Patterson Companies, Inc. in Q4 2014 and held it in 4 quarters.
  • PFM Health Sciences's Patterson Companies, Inc. position peaked at $28.8M in Q1 2017.
  • 397 funds tracked by Wall St. Rank held Patterson Companies, Inc. as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.